drugset / Trial / NCT04322760

Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery

NCT04322760 ↗

Completed 40 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

Surgery of the knee is a very common procedure which can be very painful and sufficient postoperative pain treatment is often problematic. The aim of this work was to study the effects of supplementation of intra-articular bupivacaine dexmedetomidine with lidocaine 5% patch after arthroscopic knee surgery under general anesthesia and its role in improving quality of anesthesia.

Timeline

Start
2016-12-01
Primary completion
2017-11-30
Completion
2017-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 % Topical
Background Bupivacaine Other / unclassified 0.5 % Intravenous
Background Bupivacaine Other / unclassified 10 ml Intravenous
Background Dexmedetomidine Other / unclassified 1 ug/kg Intravenous

Indications

No indication recorded.